Donor Kidney With Renal Cell Carcinoma Successfully Treated With Radiofrequency Ablation: A Case Report

S F Christensen1, J M Hansen1

  • 1Department of Nephrology, Copenhagen University Hospital Herlev, Herlev, Denmark.

Transplantation Proceedings
|December 29, 2015
PubMed
Abstract

Insights

Donor-transmitted cancer in kidney transplants is a known risk. This case details a successful radiofrequency ablation of a renal cell carcinoma found just four days post-transplant.

Area of Science:

  • Nephrology
  • Transplant Surgery
  • Oncology

Background:

  • Donor-transmitted cancer poses a significant risk in organ transplantation.
  • Early detection and management are crucial for patient outcomes.

Observation:

  • A 69-year-old female kidney transplant recipient developed a 3-cm papillary renal cell carcinoma in the allograft.
  • The tumor was detected via ultrasound just four days post-transplantation.

Findings:

  • The renal cell carcinoma was successfully treated with radiofrequency ablation.
  • Despite complications including a cutaneous fistula requiring surgical resection, the patient maintained excellent allograft function for 4.5 years.
  • Immunosuppression was adjusted to everolimus, mycophenolate, and steroids.

Implications:

  • This case highlights the possibility of rapid diagnosis of donor-transmitted tumors in renal allografts.
  • Radiofrequency ablation presents a viable treatment option for early-stage allograft tumors.
  • Successful management underscores the importance of vigilant post-transplant monitoring and tailored immunosuppression strategies.